Form 4: Heartflow CEO John Farquhar Trades Shares
Statement of Changes in Beneficial Ownership
Heartflow, Inc. CEO John Farquhar reported a transaction involving the sale of common stock, executed under a pre-arranged 10b5-1 trading plan.
Summary
- John C.M. Farquhar, CEO and Director of Heartflow, Inc., reported a transaction on April 10, 2026.
- The transaction involved the disposition of 22,562 shares of common stock at a price of $26.72 per share.
- This sale was conducted under a Rule 10b5-1 trading plan adopted by Mr. Farquhar on September 12, 2025.
- Following this transaction, Mr. Farquhar beneficially owns 549,163 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral. While it reports a significant stock sale by the CEO, the execution under a Rule 10b5-1 plan mitigates concerns about insider trading based on non-public information.
Negatives
- Insider selling of a significant number of shares, even if under a pre-arranged plan, can sometimes be perceived negatively by the market.
Risks
- The primary risk is the market's interpretation of insider selling, which could lead to negative sentiment regardless of the 10b5-1 plan.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, as it solely reports a past transaction.
Management Comments
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan indicates a pre-planned sale, often used by executives to diversify holdings or manage personal finances without appearing to trade on material non-public information. The market reaction to such sales can vary depending on the volume, the executive's role, and the company's overall performance.
Stakeholder Impact
- Shareholders: May view insider selling with caution, although the 10b5-1 plan provides a degree of reassurance against opportunistic trading.
- Employees: May be influenced by the CEO's stock disposition, potentially impacting morale or their own investment decisions.
- Creditors: Unlikely to be directly impacted by this specific transaction.
Key Dates
| Date | Description |
|---|---|
| 09/12/2025 | Date Rule 10b5-1 trading plan was adopted by Reporting Person. |
| 04/10/2026 | Transaction Date (Sale of common stock). |
| 04/14/2026 | Date of Report Signature. |
Keywords
Form 4, Insider Trading, SEC Filing, Heartflow Inc., HTFL, John Farquhar, Common Stock, Rule 10b5-1, Stock Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.